Showing results (141-150 of 1,699) with videos related to
Sort By:
Pageof 170
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2000
[Antiangiogenesis therapy and hormone therapy--their resemblance and applications of prognostic and predictive factors]M Toi, G Matsumoto, H Bando, et al.Masui. the Japanese Journal of Anesthesiology|December 10, 1999
[Usefulness of tracheal tube with N2O gas-barrier cuff]Y Umezono, A Fujita, T Toi, et al.Japanese Journal of Clinical Oncology|May 14, 2011
Recent progress in carcinogenesis, progression and therapy of breast cancer: the 20th Hiroshima Cancer Seminar--the 4th Three Universities' Consortium International Symposium, October 2010: 31 October 2010, International Conference Center HiroshimaMasakazu Toi, Wataru Yasui, Hisao Ito, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|December 24, 2010
Angiogenesis in superficial esophageal squamous cell carcinoma: magnifying endoscopic observation and molecular analysisYouichi Kumagai, Masakazu Toi, Kenro Kawada, et al.Oncology Reports|May 25, 2011
Preventive effect of whole peptidoglycan (wpg) on the occurrence of rat mammary-tumors induced by 7,12-dimethylbenz(a)anthracene (dmba)M Kitamura, K Takahashi, T Tominaga, et al.Oncology Reports|May 20, 2011
Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumorsM Kitamura, K Arai, Y Iwasaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulationMariko Muta, Gaku Matsumoto, Emi Nakashima, et al.Breast Cancer Research and Treatment|January 1, 1995
Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expressionM Toi, K Inada, H Suzuki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1995
[The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient]M Toi, T Taniguchi, K Hayashi, et al.Nature Clinical Practice. Oncology|November 5, 2005
Angiogenic inhibitors: a new therapeutic strategy in oncologyGiampietro Gasparini, Raffaele Longo, Masakazu Toi, et al.Pageof 170